Stock analysts sour on Tenet Healthcare — 3 insights

According to a Norman Weekly report, stock analysts have soured on Dallas-based Tenet Healthcare.

Here's what you should know:

1. Twenty-two analysts have assigned a ranking to Tenet. Of those, nine are buy ratings, three are sell ratings and 10 are hold ratings.

2. Norman Weekly reports 41 percent of the ratings are positive overall.

3. Among large analysts, BMO Capital Markets gave Tenet an overperform rating Sept. 4, Robert W. Baird gave the stock a buy rating Sept. 28 and JP Morgan gave Tenet an underweight rating Dec. 14.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast